38 min
Dr. Xavier Barril, Gain Therapeutics, and Hartaj Singh, Oppenheimer & Co. Inc. BioTalk with Rich Bendis
-
- Business
Dr. Xavier Barril, Chief Scientific Officer, Gain Therapeutics, and Hartaj Singh, Managing Director and Senior Analyst, Oppenheimer & Co. Inc., Join BioTalk to discuss Artificial Intelligence and Machine Learning in Drug Discovery, and Wall Street’s Views on this Exciting Science.
Dr. Xavier Barril, Chief Scientific Officer, Gain Therapeutics, and Hartaj Singh, Managing Director and Senior Analyst, Oppenheimer & Co. Inc., Join BioTalk to discuss Artificial Intelligence and Machine Learning in Drug Discovery, and Wall Street’s Views on this Exciting Science.
38 min